Biotica Technology News
Most Popular Biotica Technology Story
Pfizer axes $195M Biotica pact, hands back rights to MS, lupus drugs
With plans to cut deep into its R&D budget, Pfizer is pulling out of one of its research pacts and handing back the rights to a package of new treatments it picked up in the big Wyeth buyout. And Read more...
Latest Headlines
- January 12, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
